The Viral Vector Manufacturing Market is projected to reach USD 10.65 billion by 2033, with a CAGR of 21.65%. The U.S. leads in production, expected to reach USD 3.38 billion by 2033. Major companies include Lonza, Thermo Fisher Scientific, and Charles River Laboratories. Segmentation by disease, application, type, and mode of manufacturing drives market growth.
In 2025, North America accounted for 45.31% of revenue share in the Viral Vector Manufacturing Market. Asia Pacific is expected to have the fastest growth with a projected CAGR of 22.39% over 2026-2033. Recent developments include Lonza introducing new GMP-grade cytokine and media systems, and Thermo Fisher Scientific partnering with Dr. Park CDMO for a new manufacturing facility.
Exclusive sections of the report include Capacity Utilization & Production Performance Metrics, Investment & Funding Momentum Index, Regulatory & Clinical Approval Landscape, Supply Chain & Manufacturing Footprint Analytics, and Technology & Trial Utilization Insights. These sections provide valuable insights for assessing operational efficiency, funding trends, regulatory landscape, supply chain analysis, and technology utilization in the market. The Viral Vector Manufacturing Market Report projects a market size of USD 2.23 billion in 2025 and a growth to USD 10.65 billion by 2033, with a CAGR of 21.65% from 2026 to 2033. Key segments include diseases (cancer, genetic disorders), applications (gene therapy, vaccinology), and types of vectors. Regional coverage spans North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
SNS Insider offers comprehensive market analysis and outlook on the Viral Vector Manufacturing Market. For personalized research requests, contact [email protected]. SNS Insider is a top global market research and consulting agency, providing clients with current, accurate market data and insights to navigate changing landscapes. Utilizing various research techniques, we aim to empower decision-making with confidence.
Read more at GlobeNewswire: Viral Vector Manufacturing Market to Surpass USD 10.65